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Abstract  1 
Background  2 
There is no robust evidence that screening patients with acute stroke for dysphagia reduces the risk 3 
of stroke-associated pneumonia (SAP), or of how quickly it should be done after admission. We 4 
aimed to identify if delays in bedside dysphagia screening and comprehensive dysphagia 5 
assessments by a speech and language therapist (SALT) were associated with patients' risk of SAP. 6 
Methods 7 
Nationwide registry based prospective cohort study of patients admitted with acute stroke in 8 
England and Wales. Multilevel multivariable logistic regression models were fitted, adjusting for 9 
patient variables and stroke severity. The exposures were time from 1) admission to bedside 10 
dysphagia screen, and 2) admission to comprehensive dysphagia assessment.  11 
Results 12 
Of 63650 patients admitted with acute stroke, 55838 (88%) had a dysphagia screen and 24542 (39%) 13 
a comprehensive dysphagia assessment. Patients with the longest delays in dysphagia screening (4th 14 
quartile adjusted OR 1.14, 1.03-1.24) and SALT dysphagia assessment (4th quartile adjusted OR 2.01, 15 
1.76-2.30) had a higher risk of SAP.   The risk of SAP increased in a dose-response manner with 16 
delays in SALT dysphagia assessment, with an absolute increase of pneumonia incidence of 1% per 17 
day of delay.  18 
Conclusion 19 
Delays in screening for and assessing  dysphagia after stroke, are associated with higher risk of 20 
stroke-associated pneumonia. Since stroke-associated pneumonia is one of the main causes of 21 
mortality after acute stroke, early dysphagia assessment may contribute to preventing deaths from 22 
3 
 
acute stroke and could be implemented even in settings without access to high technology specialist 1 
stroke care. 2 
3 
4 
 
Introduction 1 
Stroke-associated pneumonia (SAP)  is a common complication of acute stroke, affecting 6-10% of 2 
patients1. SAP independently increases the risk of mortality and is one of the main causes of death  3 
in the first few days and weeks after stroke2. It is also associated with worse functional outcomes, 4 
longer length of stay and increased healthcare costs3,4,5,6,7,8.  One of the main risk factors for SAP is 5 
dysphagia, which affects 37-55% of patients9 after stroke.  Dysphagia screening using a brief bedside 6 
screening tool (such as a water swallow test), and  comprehensive clinical assessments of aspiration 7 
risk by speech and language therapists (SALT), are therefore performed commonly in stroke care. 8 
Typically, all appropriate patients are screened for dysphagia and those in whom dysphagia is 9 
suspected go on to receive a comprehensive assessment. Despite being well established in clinical 10 
practice, there is however very little evidence of effectiveness for these interventions. Previous 11 
studies have generally used weak designs and provided no information to guide recommendations 12 
on how quickly dysphagia assessments after stroke should occur10,11. Swallowing assessment prior to 13 
eating and drinking is recommended in European12, United States13 and United Kingdom clinical 14 
guidelines but none recommend a specific approach to assessment or treatment of dysphagia.  15 
As SAP develops most frequently within the first 7 days of stroke1, the timing of both dysphagia 16 
screening and SALT assessment after admission are likely to be of importance. In England and Wales, 17 
dysphagia screening is recommended within 4 h of admission for acute stroke, and comprehensive 18 
assessment by a SALT (if required) within 72 h of admission 14 . The aim of this study was to 19 
investigate the association between delays in dysphagia screening and SALT assessment and the 20 
incidence SAP within the first 7 days after admission. The hypothesis was that delays in these 21 
assessments would be associated with an increased incidence of SAP. 22 
 23 
  24 
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Methods 1 
Data were from the Sentinel Stroke National Audit Programme (SSNAP), the national register of 2 
stroke in England and Wales, of patients aged ≥16 years admitted with acute stroke (ischaemic 3 
stroke or primary intracerebral haemorrhage) between April 2013 and March 2014. SSNAP is a 4 
prospective continuous register with participation from all hospitals admitting adults with stroke in 5 
England and Wales and is estimated to include 90-95% of all stroke admissions15. Ethical approval of 6 
SSNAP was granted by the Ethics and Confidentiality Committee of the National Information 7 
Governance Board. Mortality data were obtained through data linkage with the statutory register of 8 
deaths.  Data linkage was carried out by a third party and the investigators used an anonymised 9 
dataset with all patient identifiers removed. 10 
Dysphagia screening was defined as use of a bedside swallow screening test by an appropriately 11 
trained clinician (typically a trained nurse). The exact dysphagia screening protocol was not specified 12 
by SSNAP.  The times from admission to documented dysphagia screen and comprehensive 13 
assessment by SALT were recorded to the nearest minute for all patients in whom these were 14 
carried out. For patients who had a stroke as an inpatient, the time from stroke onset was used 15 
instead of time of admission. All patients without clinical exclusions (e.g. being treated palliatively 16 
only) were eligible for dysphagia screening, and eligibility for comprehensive dysphagia assessment 17 
was determined by clinical indications, such as a positive dysphagia screen or clinical suspicion of 18 
dysphagia. Patients (n=965) admitted directly to an intensive care unit (ICU) on admission were 19 
excluded from the primary analysis, since most of these patients would have been intubated. 20 
SAP was defined as the administration of antibiotics for a new clinical diagnosis of pneumonia in the 21 
first seven days after admission and was determined by the treating physician.   22 
Statistical analysis 23 
6 
 
The adjusted odds of SAP were estimated by fitting multivariable logistic regression models. Time 1 
from admission to dysphagia screen and SALT dysphagia assessment were analysed both as 2 
continuous variables and by division into quartiles. When included as a continuous variable they 3 
were fitted as restricted cubic regression splines using the POSTRCSPLINE module16. Spline 4 
coefficients cannot be interpreted directly and so the models were displayed graphically, showing 5 
the modelled association (and 95% confidence interval) between time to dysphagia screen or 6 
comprehensive dysphagia assessment and estimated adjusted SAP incidence. Multilevel 7 
multivariable logistic regression models were also fitted using quartiles of these times to enable 8 
quantification of the study results into odds ratios and also to account for clustering at the hospital 9 
level. These models were specified as two level models with hospital level random intercepts.  10 
All models included age, sex, stroke subtype (ischaemic, primary intracererbral haemorrhage, or 11 
undetermined), pre stroke functional level using the modified Rankin Scale (mRS), place of stroke 12 
(out of hospital or inpatient), vascular comorbidity (heart failure, hypertension, atrial fibrillation, 13 
diabetes mellitus, previous stroke or transient ischaemic attack) and either NIH Stroke Scale (NIHSS) 14 
or level of consciousness on admission.  15 
Data were complete for all data items apart from the NIHSS on admission, which was available for 16 
73% of patients. Models were therefore also fitted using level of consciousness on admission as a 17 
proxy for severity (available for 100% of patients) and the results of the models compared to explore 18 
the effect of these missing data on the results. 19 
We carried out several sensitivity analyses. Firstly, competing risk from early mortality was explored 20 
by excluding patients dying or starting palliative care in the first 3 days. Secondly, models were fitted 21 
including a variable indicating change (increase, no change, decrease) in the level of consciousness in 22 
the first seven days after stroke, to explore the possible confounding effect of changing 23 
consciousness level. Thirdly, ICU patients excluded in the main analysis were included in a complete 24 
data set analysis.  Fourthly, time from admission to stroke unit admission was included in the models 25 
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as a possible confounder. Finally, we fitted models of 30 day all cause mortality, excluding patients 1 
dying or starting palliative care in the first 3 days (on the grounds that death in these latter patients 2 
is more likely due directly to brain injury from the stroke rather than stroke associated pneumonia). 3 
These models explored whether delays in dysphagia screening and assessment were associated with 4 
mortality after stroke.  5 
8 
 
Results 1 
There were 63650 patients with acute stroke included in the cohort, admitted to 199 hospitals. Of 2 
these, 55838 (87.7%) had a dysphagia screen, and 24542 (38.6%) proceeded to a comprehensive 3 
assessment. The characteristics of the whole cohort, and the subgroups of patients according to 4 
receipt of dysphagia screening and comprehensive dysphagia assessment are described in Table 1. 5 
Patients in whom a dysphagia screen was not performed had a greater incidence of inpatient stroke 6 
and primary intracerebral haemorrhage, lower level of consciousness on admission and were less 7 
likely to have NIHSS on admission completed.  8 
  9 
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Cohort 
Dysphagia 
screening not 
performed 
Dysphagia 
screening 
performed 
Comprehensive 
dysphagia 
assessment 
n (%) 63650 7812 (12.3) 55838 (87.8) 24542 (38.6) 
Median age(IQR) 77 (67-85) 80 (70-86) 77 (67-85) 80 (70-87) 
Female (n, %) 32054 (50.4) 4264 (54.5) 27790 (49.8) 13160 (53.6) 
Stroke type (n, %)     
 Ischaemic 56167 (88.2) 5948 (76.1) 50219 (91.0) 21751 (89.6) 
 
Primary intracerebral 
haemorrhage 6575 (10.3) 1592 (20.4) 4983 (8.9) 2523 (10.4) 
 Undetermined 908 (1.4) 272 (3.5) 636 (1.1) 268 (1.1) 
Inpatient stroke (n, %) 3155 (5.0) 974 (12.5) 2181 (3.9) 1599 (6.5) 
Pre-Stroke mRS (n,%)     
 0 36208 (57.9) 3808 (48.8) 32400 (58.0) 12174 (49.6) 
 1 9726 (15.3) 1109 (14.2) 8617 (15.4) 3919 (16.0) 
 2 6036 (9.5) 851 (10.9) 5185 (9.3) 2614 (10.7) 
 3 6708 (10.5) 1073 (13.7) 5635 (10.1) 3163 (12.9) 
 4 3734 (5.9) 670 (8.6) 3064 (5.5) 1988 (8.1) 
 5 1248 (2.0) 301 (3.9) 937 (1.7) 684 (2.8) 
Admission NIHSS 
complete (n,%) 46447 (73.0) 3792 (48.4) 42655 (76.4) 17041 (69.4) 
Median admission NIHSS 
(IQR) 4 (2-9) 5 (2-19) 4 (2-9) 7 (3-14) 
Level of consciousness on admission    
 0 (Alert) 53433 (84.0) 4961 (63.5) 48472 (86.8) 19156 (78.1) 
 
1 (Not alert: 
Responds to voice) 6032 (9.5) 1069 (13.7) 4963 (8.9) 3697 (15.1) 
 
2 (Not alert: 
Responds to pain) 2498 (3.9) 828 (10.6) 1670 (3.0) 1267 (5.2) 
 
3 (Totally 
unresponsive) 1687 (2.7) 954 (12.2) 733 (1.3) 422 (1.7) 
Co-morbidity (n,%)     
 Heart failure 3463 (5.4) 491 (6.3) 2972 (5.3) 1625 (6.6) 
 Hypertension 34212 (53.9) 3930 (50.3) 30382 (54.4) 13323 (54.3) 
 Atrial fibrillation 13159 (20.7) 1801 (23.1) 11358 (20.3) 5929 (24.2) 
 Diabetes mellitus 12372 (19.4) 1482 (18.9) 10890 (19.5) 4720 (19.2) 
 Previous stroke/TIA 17626 (27.7) 2144 (27.4) 15482 (27.7) 7109 (29.0) 
Time from onset to 
admission (n, %)     
Unknown (e.g. wake up 
stroke) 24668 (38.8) 4233 (54.2) 20435 (36.6) 9631 (39.2) 
0-179 minutes 21504 (33.8) 2113 (27.1) 19391 (34.7) 9086 (37.0) 
180-359 minutes 6144 (9.7) 539 (6.9) 5605 (10.0) 2289 (85.6) 
360+ minutes 11334 (17.8) 927 (11.9) 10407 (18.6) 3536 (14.4) 
Thrombolysis (n, %) 7087 (11.1) 417 (5.3) 6670 (12.0) 3415 (3.1) 
SAP (n,%) 5533 (8.7) 1077 (13.8) 4456 (8.0) 3592 (14.6) 
30 day mortality (n,%) 8397 (13.2) 2701 (34.6) 5696 (10.2) 3599 (14.7) 
 1 
Table 1. Characteristics of the study cohort 2 
10 
 
 1 
The overall incidence of SAP was 8.7%. SAP incidence was highest in the dysphagic group referred 2 
for comprehensive dysphagia assessment (14.6%). Thirty day mortality was 13.2% overall, 10.2% in 3 
patients screened for dysphagia, 14.7% in patients referred for SALT assessment, and 34.6% in 4 
patients in whom a dysphagia screen was not carried out. 5 
The median time from admission to dysphagia screening was 2.9 hours (IQR 1.3-5.7 hours) and for 6 
comprehensive dysphagia assessment was 22.9 hours (IQR 6.2-49.4 hours).  In unadjusted analyses 7 
there was a strong association between time from admission to dysphagia screen and incidence of 8 
SAP, rising from 7-8% from 0-8 hours and increasing to 15% by 72 hours after admission. Although 9 
the association was attenuated after adjusting for patient characteristics, there was still a modest 10 
association (equating to approximately 1% absolute increase in the incidence of SAP) between 11 
delays in dysphagia screening and incidence of SAP (Figure 1). After adjustment, patients in the 12 
fourth quartile (i.e. those with the longest delays in dysphagia screening) had 36% higher odds of 13 
SAP compared to those in the first quartile  (aOR 1.36, 1.20-1.53)  (Table 2).  14 
  15 
11 
 
  Time (mins) OR 95% CI p 
Univariable 
(n=55838) 
1st quartile 0-79 REF   
2nd quartile 80-176 0.89 0.81-0.98 0.016 
3rd quartile 177-344 0.85 0.77-0.94 0.001 
4th quartile ≥345 1.33 1.21-1.46 <0.0001 
Multivariable, including 
NIHSS 
(n=42655) 
1st quartile 0-79 REF   
2nd quartile 80-176 0.94 0.83-1.05 0.27 
3rd quartile 177-344 1.06 0.94-1.20 0.36 
4th quartile ≥345 1.36 1.20-1.53 <0.0001 
Multivariable, including 
level of consciousness 
(n=55838) 
1st quartile 0-79 REF   
2nd quartile 80-176 0.92 0.83-1.01 0.08 
3rd quartile 177-344 0.89 0.81-0.99 0.03 
4th quartile ≥345 1.14 1.03-1.24 0.008 
 1 
Table 2. Odds ratio for SAP in univariable and multivariable models of time from admission to 2 
dysphagia screening. All multivariable models were also adjusted for age, sex, stroke type, pre-3 
stroke functional level, place of stroke and comorbidity, and measure of stroke severity (NIHSS or 4 
level of consciousness) 5 
 6 
There was a strong relationship between delays in comprehensive dysphagia assessment and 7 
incidence of SAP, and delays in comprehensive dysphagia assessment were associated with an 8 
absolute increase in the risk  of SAP of 3% over the first 24 hours (Figure 2). Delays in SALT dysphagia 9 
assessment beyond 24 hours were associated with an additional 4% absolute increase in the 10 
incidence of SAP (approximately 3-fold increase in the relative incidence).  Patients in the slowest 11 
quartile had 1.98 (1.67-2.35) the odds of SAP compared to patients receiving the quickest SALT 12 
dysphagia assessments (Table 3). Findings were similar in the sensitivity analyses (Supplementary 13 
material). The secondary analysis of 30 day mortality broadly supported these findings: there was 14 
very weak evidence that delays in dysphagia assessment were associated with an increase in 30 day 15 
mortality (aOR 1.14, 0.99-1.30 in the slowest quarter). There was moderately strong evidence that 16 
delays in comprehensive SLT assessment were associated with an increase in mortality risk in the 17 
second (aOR 1.22, 1.02-1.47), third (aOR 1.55, 1.29-1.85) and fourth (aOR 1.35, 1.12-1.63) quarters 18 
12 
 
of time to assessment respectively. Unlike pneumonia, a dose-response relationship was not 1 
demonstrated for the association with mortality (Supplementary material)   2 
13 
 
 1 
  Time (mins) OR 95% CI p 
Univariable 
(n=24542) 
1st quartile 0-369 REF   
2nd quartile 370-1371 1.53 1.34-1.74 <0.0001 
3rd quartile 1372-2961 1.95 1.71-2.22 <0.0001 
4th quartile ≥2962 2.65 2.33-3.01 <0.0001 
Multivariable, 
including NIHSS 
(n=17041) 
1st quartile 0-369 REF   
2nd quartile 370-1371 1.35 1.15-1.60 <0.0001 
3rd quartile 1372-2961 1.61 1.37-1.91 <0.0001 
4th quartile ≥2962 1.98 1.67-2.35 <0.0001 
Multivariable, 
including level of 
consciousness 
(n=24542) 
1st quartile 0-369 REF   
2nd quartile 370-1371 1.40 1.22-1.60 <0.0001 
3rd quartile 1372-2961 1.60 1.41-1.84 <0.0001 
4th quartile ≥2962 2.01 1.76-2.30 <0.0001 
 2 
Table 3. Odds ratio for SAP in univariable and multivariable models of time from admission to SALT 3 
dysphagia assessment. All multivariable models were also adjusted for age, sex, stroke type, pre-4 
stroke functional level, place of stroke and comorbidity, and measure of stroke severity (NIHSS or 5 
level of consciousness) 6 
 7 
  8 
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Discussion 1 
In this national cohort of unselected stroke patients, we found that there was evidence of a modest 2 
association between delays in performing dysphagia screening and the risk of SAP. There was 3 
stronger evidence for an  association between the risk of SAP and delays in carrying out a 4 
comprehensive dysphagia assessment. Although limited by the risk of residual confounding, these 5 
findings provide the first evidence from a large multicentre cohort that prompt dysphagia screening 6 
and comprehensive dysphagia assessment stroke are associated with clinically significant reductions 7 
in the risk of SAP, one of the principal causes of early death after stroke. 8 
Detecting dysphagia through the use of bedside screening assessments and comprehensive 9 
dysphagia assessments carried out by a SALT is widely recommended in clinical guidelines12-14. 10 
However, these recommendations are largely based on consensus and there is little direct evidence 11 
for dysphagia screening or assessment after stroke17. Previous studies have been limited to 12 
ecological studies demonstrating an association between site level rates of screening assessment 13 
and SAP rates after stroke8,10,11. Several observational studies have described an association between 14 
dysphagia screening at any time after stroke and reduced post stroke mortality10,18,19,20, and 15 
dysphagia screening was a component of a stroke care bundle found in a cluster randomised 16 
controlled trial to reduce death and dependency after stroke21. By contrast, an analysis of the “Get 17 
with the Guidelines – Stroke” registry data from the USA found that dysphagia screening was 18 
associated with a higher risk of SAP, although  the results suggest that confounding by stroke 19 
severity contributed to the observed association22. There is no current evidence of how quickly 20 
dysphagia assessment should occur after stroke or good quality evidence of whether dysphagia 21 
assessment reduces the risk of SAP. As a result of this lack of evidence, dysphagia screening has been 22 
dropped from the list of stroke quality indicators used in the USA23, although they remain part of 23 
quality indicators used in the UK24. 24 
15 
 
If our findings represent causal effects, then they imply that dysphagia screening and assessment is 1 
effective in reducing the risk of SAP. Since SAP is one of the main causes of death in acute stroke, 2 
reducing the risk of SAP would be expected to lead to reduced mortality after stroke. The secondary 3 
analyses of mortality in this study provide supporting evidence that this might be the case. We 4 
would however emphasise caution in interpreting the mortality findings - there are many causes of 5 
death in acute stroke and so reductions in SAP will only prevent a proportion of deaths (in keeping 6 
with the reduced effect sizes for mortality we observed) and we did not observe a dose-response 7 
relationship between delays in comprehensive dysphagia assessment and mortality, suggesting that 8 
there might be additional confounding or bias not accounted for in the analysis. 9 
There are several possible mechanisms for why delays in dysphagia assessment might lead to an 10 
increased risk of SAP and further studies would be required to  test these hypotheses and confirm 11 
(or refute) a causal relationship: early screening may reduce the risk of inappropriate administration 12 
of oral fluid or food, prompt measures to reduce aspiration risk through positioning, nursing care 13 
and appropriate feeding strategies, and avoid unnecessary nasogastric tube insertions. As well as 14 
exploring mechanisms, further research might usefully also explore organisational aspects of 15 
dysphagia assessment, such as the use of specific assessment and treatment protocols and the 16 
relationship between specialist SALT provision on stroke units and patient outcomes.  17 
These data are strengthened by being drawn from a national register of unselected patients, 18 
reducing the risk of selection bias. Similarly, the study used clinical rather than administrative data, 19 
providing more detail than would be available from routine administrative data alone.  There are 20 
however a number of limitations. Firstly SAP was not defined by specific criteria but was based on 21 
the judgement of the treating physician, and we did not have information on the date of diagnosis of 22 
SAP and whether it occurred before or after dysphagia screening and assessment. Nonetheless, the 23 
overall rate of SAP observed in this study is consistent with other studies, suggesting that differences 24 
in ascertainment between centres was  not a significant source of bias.  In addition, although data 25 
16 
 
completeness was high, NIHSS data were not available for one quarter of patients. We used level of 1 
consciousness as a proxy for this and found that the findings were similar, but having complete data 2 
on stroke severity may have strengthened the study. The dataset lacked information on the nature 3 
of the bedside dysphagia screening tools used, the details of the comprehensive assessment (e.g. 4 
videofluroscopy or fibre-optic evaluation of swallowing), and the results of these assessments. 5 
Further studies should aim to capture in more detail the components of these interventions. The 6 
main limitation of this study is the risk of residual confounding. The hypothesis that early dysphagia 7 
screening and SALT assessment reduce the risk of SAP could be tested in a cluster randomised 8 
controlled trial of a protocol of expedited comprehensive dysphagia assessment and this would help 9 
guide clinical practice in an important area of stroke care which currently has a poor evidence base.  10 
Implementing faster dysphagia assessments in clinical practice is principally a matter of training 11 
healthcare professionals appropriately and in most instances does not require expensive medical 12 
equipment. Dysphagia screening has been identified by the World Stroke Organisation as being 13 
achievable even in health economies with the lowest level of resources25; ensuring that all stroke 14 
patients receive rapid dysphagia assessments could therefore be a part of global efforts to improve 15 
the outcomes of acute stroke, even in settings without advanced specialist stroke care. 16 
 17 
Summary 18 
Delays in screening for dysphagia and carrying out SALT dysphagia assessments after stroke are 19 
associated with an increased risk of SAP. This hypothesis that expedited dysphagia screening and 20 
assessments reduce the risk of SAP would be testable in an appropriately designed trial or controlled 21 
evaluation. In the meantime, these findings suggest that reducing delays in screening and assessing 22 
for dysphagia in people with acute stroke should be a focus of quality improvement in stroke care.  23 
17 
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Figure 1. Modelled relationship between estimated incidence of SAP in the first seven days of 1 
admission and time to dysphagia screening. (A): Multivariable model including NIHSS.  (B): 2 
Multivariable model including level on consciousness 3 
Figure 2. Modelled relationship between estimated incidence of SAP in the first seven days of 4 
admission and the time to SALT dysphagia assessment. (A): Multivariable model including NIHSS.  5 
(B): Multivariable model including level on consciousness 6 
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